On September 3, 2025, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) released a report highlighting explosive growth in Medicare Part B spending on skin ...
The HHS Office of the Inspector General (OIG) called out sky-high spending on pricey skin substitutes and voiced concerns about potential waste, fraud, and abuse in a report released earlier this ...
Starting Jan. 1, 2026, Medicare will overhaul how it pays for most skin substitute products, moving from ASP-based reimbursement to a standardized flat rate of $127.28/cm². The change, finalized Nov.
Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers. Credit...Photo illustration by The New York Times Supported by By Sarah ...
The runaway costs of skin substitutes for treating chronic wounds have experts and accountable care organizations (ACOs) ...